Clinical Trial Update: Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer

View source ↗

Summary

An update on a clinical trial evaluating hypermethylated DNA as a diagnostic biomarker for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | Conditions: Colorectal Neoplasms, Aberrant DNA Methylation | Status: UNKNOWN